共 37 条
[1]
Kalogeraki A(2012)Cytopathologic interpretation of ascites due to malignancy J buon 17 446-451
[2]
Hodge C(2019)Palliation of malignant ascites J Surgical Oncol 120 67-73
[3]
Badgwell BD(2015)Evaluation and treatment of malignant ascites secondary to gastric cancer World J Gastroenterol 21 10936-10947
[4]
Maeda H(2019)Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: morbidity and postoperative outcomes Minerva Chir 74 195-202
[5]
Kobayashi M(2015)Gastrointestinal cancers with peritoneal carcinomatosis: surgery and hyperthermic intraperitoneal chemotherapy Oncology (Williston Park) 29 515-521
[6]
Sakamoto J(2018)Hyperthermic intraperitoneal chemotherapy (HIPEC). Mechanisms of action and the role of HIPEC in the treatment of peritoneal carcinomatosis Ann Ital Chir 89 513-527
[7]
Robella M(2019)Hyperthermic intraperitoneal chemotherapy Chirurg 90 593-604
[8]
Loggie BW(2015)Review article: spontaneous bacterial peritonitis--bacteriology, diagnosis, treatment, risk factors and prevention Aliment Pharmacol Ther 41 1116-1131
[9]
Thomas P(2017)Supportive care for patients undergoing immunotherapy Support Care Cancer 25 3017-3030
[10]
Bartos A(2009)Management of ascites due to gastrointestinal malignancy Ann Saudi Med 29 369-377